Financial BioRestorative Therapies Reports First Quarter 2025 Financial Results and Provides Business Update byTim AllenMay 14, 2025
Financial Aclarion Provides Update on Strength of Company Positioning Following Q1 Strategic Initiatives byTim AllenMarch 31, 2025
Financial Regulatory Spine Top Stories SPINEWAY: Update on the legal proceedings against Strategos byJosh SandbergMarch 21, 2025
Spine Top Stories Aclarion Provides Corporate Update on Nociscan AI Technology Milestones byJosh SandbergSeptember 12, 2024
Biologics Financial Spine Top Stories Orthofix Provides Executive Management Business Update and Appoints Julie Andrews as Chief Financial Officer byJosh SandbergJanuary 8, 2024
Financial Paragon 28 Announces New $150 Million Credit Facility Replacing Existing $90 Million Credit Facility byJosh SandbergNovember 7, 2023
Extremities Regulatory Bioretec postpones Annual General Meeting to a later date byJosh SandbergMarch 17, 2023
Financial Hospitals Tenet beating expectations; announces leadership changes byJosh SandbergJanuary 20, 2023
Regulatory Top Stories Bioretec updates its estimate of the timing for approval of the CE mark for the RemeOs™ trauma screw byJosh SandbergNovember 4, 2022
Biologics Financial Spine Bone Biologics CEO Issues Letter to Stockholders byChris StewartOctober 25, 2022
